Highlights from Adaptive Biotechnologies at FOCIS 2021

Turning large-scale immune repertoire data into actionable insights: Lessons from COVID-19, other infectious diseases, and autoimmunity

This presentation provides an overview of:

  • The principles behind the Adaptive Biotechnologies immune-medicine platform, particularly the immunoSEQ® Technology
  • Learnings from over a year of COVID-19 research, including identification of public T-cell receptors to detect recent of past T-cell immune response to infection, track responses to vaccines, and study emerging variants
  • The impact of COVID-19 in other therapeutic areas
  • Extensions of the technology into other diseases, from assessing prior CMV infection to possibly detecting Lyme disease and Crohn’s disease

Presented by: Thomas Snyder, VP Research, Adaptive Biotechnologies

Machine learning approaches to developing TCR repertoire-based diagnostics for pathogen exposure

Learn how the immunoSEQ Technology and machine learning approaches were used to identify disease-specific TCRB sequences for CMV, COVID-19, and gather insights on HLA.

Presented by: Paul Fields, Senior Manager Computational Biology, Adaptive Biotechnologies

Register for SEQdiscovery

To access this video, poster and all SEQdiscovery content.
If you have previously registered and opted to have an account please log in above.